Abstract: This article introduces the principles of the talkative power converter/conversion (TPC) in an ac system, demonstrated through its application in a three-phase power factor correction (PFC) ...

When thinking about weight loss, metabolism is a major factor. Understanding your metabolic rate (the speed at which your body burns calories) along with your daily caloric needs is crucial for ...

Abstract: This study aims to investigate the frequency spectral characteristics of a simplified active power factor correction (APFC) converter. The proposed model is developed to predict harmonics ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's ...

Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D ...